Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Reuters: “Many U.S. cancer patients struggle to afford life-saving medications"
February 22, 2017 Madeline Kennedy As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with paying for prescription medications, according to a recent study. The financial burdens are especially high for patients under age 65 who cannot access Medicare, the government insurance program for the elderly, and […]
News and Reports
Kaiser Health News: “Sky-High Prices For Orphan Drugs Slam American Families And Insurers”
January 17, 2017 Sarah Jane Tribble and Sydney Lupkin Before Luke Whitbeck began taking a $300,000-a-year drug, the 2-year-old’s health was inexplicably failing. A pale boy with enormous eyes, Luke frequently ran high fevers, tired easily and was skinny all over, except his belly stuck out like a bowling ball. “What does your medicine do […]
News and Reports
STAT News: “Behind patient advocacy groups, donors are exerting a powerful force, study says”
January 17, 2017 Sheila Kaplan WASHINGTON — At a time when drug company lobbyists are widely vilified as icons of avarice, patient advocacy groups still wear the white hats. But those organizations, which promote cures for every type of cancer and hundreds more diseases, have come under criticism lately for favoring their drug company funders […]
News and Reports
Washington Post: “Trump vows ‘insurance for everybody’ in Obamacare replacement plan”
January 15, 2017 Robert Costa and Amy Goldstein President-elect Donald Trump said in a weekend interview that he is nearing completion of a plan to replace President Obama’s signature health-care law with the goal of “insurance for everybody,” while also vowing to force drug companies to negotiate directly with the government on prices in Medicare […]
News and Reports
New York Times: “Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits”
December 19, 2016 Matt Richtel and Andrew Pollack Enthusiasm for cancer immunotherapy is soaring, and so is Arie Belldegrun’s fortune. Dr. Belldegrun, a physician, co-founded Kite Pharma, a company that could be the first to market next year with a highly anticipated new immunotherapy treatment. But even without a product, Dr. Belldegrun has struck gold. […]
News and Reports
US News: “The Harm of High Drug Prices”
December 12, 2016 Hagop Kantarjian and Vivian Ho The problem of high cancer drug prices in the United States was highlighted in 2013, following a decade during which the average annual price of newly introduced cancer drugs increased from less than $10,000 to more than $100,000 in 2012. In a for-profit health care industry, drug […]
News and Reports
New York Times: “Lives and Profits in the Balance: The High Stakes of Medical Patents”
December 11, 2016 Clyde Haberman “The West Wing,” Aaron Sorkin’s television series about a fictional White House, had a knack for crisply summarizing complex real-life issues. In an episode from 2000, pharmaceutical executives and leaders of an AIDS-plagued African country are summoned to the White House. The purpose is to see if reluctant businessmen can […]
News and Reports
December 1, 2016 David S. Hilzenrath At an August 15, 2016, public forum convened by the Food and Drug Administration, panelist Marc Boutin introduced himself as CEO of National Health Council and said his organization provides “a united voice for people with chronic disease and disabilities.” Speaking at the agency’s invitation, he proceeded to praise […]